Filing Flows › Bio-Techne (TECH) › Q4 FY26
Bio-Techne (TECH) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Aug 24, 2026
Bio-Techne (TECH) reported revenue of $321M for the fourth quarter fiscal 2026 (Q4 FY26), +1% from a year earlier and +3% from the quarter before. Operating margin was 23.1%, net earnings $54.6M (17.0% of revenue).
Bio-Techne, Q4 FY26: revenue $321M (+1% year over year), operating margin 23.1%, net earnings $54.6M, operating cash flow $95.4M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $321M | +3% | +1% |
| Gross profit | $211M | +1% | +6% |
| Operating profit | $74.3M | -2% | — |
| Net earnings | $54.6M | +7% | — |
| Operating cash flow | $95.4M | +10% | -3% |
| Free cash flow | $86.9M | +12% | -7% |
What changed
Revenue was $321.2M in Q4 FY26, up 1% year over year and up 3% from the previous quarter. Consumables was the largest line at 81% of revenue.
Gross margin was 65.8%, up 3.1 points from Q4 FY25. Operating profit was $74.3M, a 23.1% margin (up 30.7 points year over year). Operating expenses fell 38% while revenue rose 1%. Net earnings were $54.6M. The effective tax rate was 22.7%.
Operating cash flow was $95.4M (down 3% year over year), 175% of net earnings. Non-cash charges added back $24.1M of depreciation and amortization and $5.2M of share-based compensation. Working capital and other items added $11.4M. Capital expenditures of $8.5M left free cash flow of $86.9M.
Questions
What was Bio-Techne's revenue in the fourth quarter fiscal 2026?
Bio-Techne (TECH) reported revenue of $321M for the fourth quarter fiscal 2026 (Q4 FY26), +1% from a year earlier and +3% from the quarter before.
Was Bio-Techne profitable in the fourth quarter fiscal 2026?
Operating profit was $74.3M (23.1% of revenue) and net earnings $54.6M.
Source: Bio-Techne 10-K on SEC EDGAR.